- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Tandem Diabetes Care Inc DRC (T2ND34)
Tandem Diabetes Care Inc DRC stock price live, this page displays BVMF T2ND34 stock exchange data. View the T2ND34 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Tandem Diabetes Care Inc DRC real time stock price chart below.
What Is the Tandem Diabetes Care Inc DRC Stock Price Today?
The Tandem Diabetes Care Inc DRC stock price today is 7.67.
What Is the Stock Symbol for Tandem Diabetes Care Inc DRC?
The stock symbol for Tandem Diabetes Care Inc DRC is "T2ND34."
What Stock Exchange Does Tandem Diabetes Care Inc DRC Trade On?
Tandem Diabetes Care Inc DRC is listed and trades on the B3 stock exchange.
Is Tandem Diabetes Care Inc DRC a Good Stock to Buy?
Determining whether Tandem Diabetes Care Inc DRC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the T2ND34 quote. (ISIN: BRT2NDBDR007)
What Is the Tandem Diabetes Care Inc DRC Stock Price Today?
The Tandem Diabetes Care Inc DRC stock price today is 7.67.
What Is the Stock Symbol for Tandem Diabetes Care Inc DRC?
The stock symbol for Tandem Diabetes Care Inc DRC is "T2ND34."
What Stock Exchange Does Tandem Diabetes Care Inc DRC Trade On?
Tandem Diabetes Care Inc DRC is listed and trades on the B3 stock exchange.
Is Tandem Diabetes Care Inc DRC a Good Stock to Buy?
Determining whether Tandem Diabetes Care Inc DRC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the T2ND34 quote. (ISIN: BRT2NDBDR007)
7.67
-0.33(-4.13%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
7.65
7.68
52 wk Range
6.35
17.29
T2ND34 Scorecard
Full Analysis
Stock price movements are quite volatile
Unusual trading volume
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
7.657.68
52 wk Range
6.3517.29
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
T2ND34 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts do not anticipate the company will be profitable this year
- Tandem Diabetes partners with Abbott for integration
- Investing.com
- Tandem Diabetes Care gets FDA clearance for new set
- Investing.com
- Tandem Diabetes partners with Abbott for integration
- Investing.com
Tandem Diabetes Care Inc DRC Company Profile
Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company’s flagship product is the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user’s body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. It has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.
Compare T2ND34 to Peers and Sector
Metrics to compare | T2ND34 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipT2ND34PeersSector | |
|---|---|---|---|---|
P/E Ratio | −7.5x | −7.4x | −0.5x | |
PEG Ratio | 0.26 | −0.10 | 0.00 | |
Price/Book | 8.9x | 2.5x | 2.6x | |
Price / LTM Sales | 1.4x | 2.1x | 3.1x | |
Upside (Analyst Target) | - | 69.1% | 50.4% | |
Fair Value Upside | Unlock | −5.6% | 8.7% | Unlock |
Earnings
Latest Release
Apr 30, 2025
EPS / Forecast
-1.97 / --
Revenue / Forecast
234.42M / --
FAQ
What Is the Tandem Diabetes Care DRC (T2ND34) Stock Price Today?
The Tandem Diabetes Care DRC stock price today is 7.67
What Stock Exchange Does Tandem Diabetes Care DRC Trade On?
Tandem Diabetes Care DRC is listed and trades on the B3 Stock Exchange stock exchange.
What Is the Stock Symbol for Tandem Diabetes Care DRC?
The stock symbol for Tandem Diabetes Care DRC is "T2ND34."
What Is the Tandem Diabetes Care DRC Market Cap?
As of today, Tandem Diabetes Care DRC market cap is 7.67B.
What Is Tandem Diabetes Care DRC's Earnings Per Share (TTM)?
The Tandem Diabetes Care DRC EPS (TTM) is -2.80.
From a Technical Analysis Perspective, Is T2ND34 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Tandem Diabetes Care DRC Stock Split?
Tandem Diabetes Care DRC has split 0 times.
How Many Employees Does Tandem Diabetes Care DRC Have?
Tandem Diabetes Care DRC has 2650 employees.
What is the current trading status of Tandem Diabetes Care DRC (T2ND34)?
As of 14 June 2025, Tandem Diabetes Care DRC (T2ND34) is trading at a price of 7.67, with a previous close of 8.00. The stock has fluctuated within a day range of 7.65 to 7.68, while its 52-week range spans from 6.35 to 17.29.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.